BROWARD HEALTH IMPERIAL POINT — History
CCN 100200 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$117M
Latest Revenue (FY2022)
+8.2%
Revenue CAGR (3yr)
-16.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $100M | $110M | $117M | +6.9% | +8.2% |
| Operating Expenses | $119M | $139M | $137M | -1.5% | +7.1% |
| Operating Margin | -18.9% | -26.5% | -16.6% | +37.6% | +0.0% |
| Net Income | $-19M | $-29M | $-19M | +33.3% | +0.0% |
| Licensed Beds | 157 | 157 | 157 | +0.0% | +0.0% |
| Total Patient Days | 22,575 | 21,294 | 18,324 | -13.9% | -9.9% |
| Medicare Day % | 20% | 21% | 21% | -0.2% | +2.2% |
| Medicaid Day % | 7% | 4% | 4% | +13.2% | -21.1% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.0% ($100M → $117M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.2%
This Hospital
+7.6%
State Avg
Latest Margin
-16.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $126M | -15.4% |
| FY2024 (proj) | $134M | -14.3% |
| FY2025 (proj) | $143M | -13.1% |